Allarity Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Allarity Therapeutics, Inc. (ALLR) reported Foreign Currency Transaction Gain (Loss), before Tax of -$104.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-14
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$104.00K, a 106.55% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $4.00K, a 97.10% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was -$551.00K.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$418.00K, a 445.45% decline year-over-year.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2025 was $757.00K.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$212.00K, a 259.40% decline from fiscal 2023.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2023 was $133.00K.
- Allarity Therapeutics, Inc. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$913.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$104.00K 10-Q · filed 2026-08-14 | -$100.00K 10-Q · filed 2026-08-14 | -$651.00K derived: sum of 3 quarters · filed 2026-08-14 | -$1.07M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-15 | -$547.00K derived: sum of 2 quarters · filed 2026-05-15 | -$965.00K derived: sum of 3 quarters · filed 2026-05-15 | $623.00K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | -$551.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$969.00K derived: sum of 2 quarters · filed 2026-03-30 | $619.00K derived: sum of 3 quarters · filed 2026-08-14 | $757.00K 10-K · filed 2026-03-30 | ||
| 2025-09-30 | -$418.00K 10-Q · filed 2025-11-14 | $1.17M derived: sum of 2 quarters · filed 2026-08-14 | $1.31M 10-Q · filed 2025-11-14 | $1.03M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $1.59M 10-Q · filed 2026-08-14 | $1.73M 10-Q · filed 2026-08-14 | $1.45M derived: sum of 3 quarters · filed 2026-08-14 | $1.57M derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-03-31 | $138.00K 10-Q · filed 2026-05-15 | -$143.00K derived: sum of 2 quarters · filed 2026-05-15 | -$22.00K derived: sum of 3 quarters · filed 2026-05-15 | -$150.00K derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | -$281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$160.00K derived: sum of 2 quarters · filed 2026-03-30 | -$288.00K derived: sum of 3 quarters · filed 2026-03-30 | -$212.00K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $121.00K 10-Q · filed 2025-11-14 | -$7.00K derived: sum of 2 quarters · filed 2025-11-14 | $69.00K 10-Q · filed 2025-11-14 | $289.00K derived: sum of 4 quarters · filed 2025-11-14 | ||
| 2024-06-30 | -$128.00K 10-Q · filed 2025-08-15 | -$52.00K 10-Q · filed 2025-08-15 | $168.00K derived: sum of 3 quarters · filed 2025-08-15 | $12.00K derived: sum of 4 quarters · filed 2025-08-15 | ||
| 2024-03-31 | $76.00K 10-Q · filed 2025-05-09 | $296.00K derived: sum of 2 quarters · filed 2025-05-09 | $140.00K derived: sum of 3 quarters · filed 2025-05-09 | $114.00K derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $220.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $64.00K derived: sum of 2 quarters · filed 2025-03-31 | $38.00K derived: sum of 3 quarters · filed 2025-03-31 | $133.00K 10-K · filed 2025-03-31 | ||
| 2023-09-30 | -$156.00K 10-Q · filed 2024-11-14 | -$182.00K derived: sum of 2 quarters · filed 2024-11-14 | -$87.00K 10-Q · filed 2024-11-14 | -$56.00K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$26.00K 10-Q · filed 2024-08-05 | $69.00K 10-Q · filed 2024-08-05 | $100.00K derived: sum of 3 quarters · filed 2024-08-05 | -$306.00K derived: sum of 4 quarters · filed 2024-08-05 | ||
| 2023-03-31 | $95.00K 10-Q · filed 2024-05-14 | $126.00K derived: sum of 2 quarters · filed 2024-05-14 | -$280.00K derived: sum of 3 quarters · filed 2024-05-14 | -$549.00K derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | -$375.00K derived: sum of 2 quarters · filed 2024-03-08 | -$644.00K derived: sum of 3 quarters · filed 2024-03-08 | -$913.00K 10-K · filed 2024-03-08 | ||
| 2022-09-30 | -$406.00K 10-Q · filed 2023-11-14 | -$675.00K derived: sum of 2 quarters · filed 2023-11-14 | -$944.00K 10-Q · filed 2023-11-14 | -$968.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | -$269.00K 10-Q · filed 2023-08-14 | -$538.00K 10-Q · filed 2023-08-14 | -$562.00K derived: sum of 3 quarters · filed 2023-08-14 | -$553.00K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | -$269.00K 10-Q · filed 2023-05-11 | -$293.00K derived: sum of 2 quarters · filed 2023-05-11 | -$284.00K derived: sum of 3 quarters · filed 2023-05-11 | -$325.00K derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2021-12-31 | -$24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | -$15.00K derived: sum of 2 quarters · filed 2023-03-13 | -$56.00K derived: sum of 3 quarters · filed 2023-03-13 | -$95.00K 10-K · filed 2023-03-13 | ||
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-14 | -$51.00K 10-Q · filed 2021-11-23 | -$32.00K derived: sum of 2 quarters · filed 2022-11-14 | -$71.00K 10-Q · filed 2022-11-14 | $29.00K 10-Q · filed 2021-11-23 | -$127.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | -$41.00K 10-Q · filed 2022-10-07 | -$80.00K 10-Q · filed 2022-10-07 | -$136.00K derived: sum of 3 quarters · filed 2022-10-07 | -$104.00K derived: sum of 4 quarters · filed 2022-10-07 | ||
| 2021-03-31 | -$39.00K 10-Q · filed 2022-05-27 | -$95.00K derived: sum of 2 quarters · filed 2022-05-27 | -$63.00K derived: sum of 3 quarters · filed 2022-05-27 | |||
| 2020-12-31 | -$56.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | -$24.00K derived: sum of 2 quarters · filed 2022-05-17 | $62.00K 10-K · filed 2022-05-17 | |||
| 2020-09-30 | $32.00K 10-Q/A · filed 2022-05-17 | -$32.00K 10-Q · filed 2021-11-23 | $118.00K 10-Q/A · filed 2022-05-17 | -$118.00K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |